Key Issues in FDA & FTC Regulation of Dietary Supplements 2013

Topics

• Recent FDA enforcement action on dietary supplement GMPs
• Overview of dietary supplement regulation
• Understanding when claims convert a dietary supplement into a drug and the consequences of the resulting unapproved new drug status
• Changes in FDA’s New Dietary Ingredient (NDI) requirements
• The FTC’s decision in POM Wonderful and its implications for claims substantiation

Who should Attend

C-Suite / Senior Executives from dietary supplement companies involved in:

• Quality Assurance
• Manufacturing
• Compliance
• Regulatory Affairs
• Marketing
• Sales
• Scientific Affairs
• Legal
• Clinical